Table: begin end state 1 36 non-cytoplasmic 37 58 transmembrane 59 65 cytoplasmic 66 86 transmembrane 87 105 non-cytoplasmic 106 127 transmembrane 128 134 cytoplasmic 135 155 transmembrane 156 183 non-cytoplasmic 184 203 transmembrane 204 209 cytoplasmic 210 228 transmembrane 229 260 non-cytoplasmic 261 283 transmembrane 284 297 cytoplasmic 298 320 transmembrane 321 333 non-cytoplasmic 334 374 transmembrane 375 391 non-cytoplasmic 392 420 transmembrane 421 569 cytoplasmic
Input: >WP_011386051.1 NCBI__GCF_000009985.1:WP_011386051.1 MSERPTFMPARLINLFTPKLLVCLKEGYDLPRGRGDLIAGLTVAIVALPLAMALGIASGV TPDRGLFTAIVAGFLISFLGGSRFQIGGPTGAFVVVVYNIVQQHGYDGLVLATLMAGVML LLFGLARFGVVIKYIPYPLVTGFTSGIAVIIFSSQVKDFLGLRMESVPAEFFEKWVAYGE HIGTTHGPTLAVAAGTLAVILVLRRFRPGWPGFLIGVTGASVLVWALGMPVETIGSRFGG IPSTLPSPQFPALSWGKVTALLQPAFTIAFLAGIESLLSAMVADGMTGRRHKSNCELLAQ GIANIASVLFGGIPATGAIARTATSIKSGAQTPVAGMLHAVFILLFMLLFAPLASWIPLP SLAAVLMVVAWNMSEAPHFIHLMSAPRSDRAVLLVTFVLTVMVDLTVAIEVGMVLASILF MRRMAEVTEIGTGIHLIDEDAEDGGDDHVGAIPTTPIPDGVEVFQISGPFFFGVATRLSE VFEQTHKPPRVFILRMRLVPVIDASGIQALTEFVRRCRKHGTEVLLSGVQPQPMQVMGRM GLCHEIGEDNFVPNIDAALTTARTLAVHP
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server